Life sciences and healthcare-focused private equity house Ampersand Capital Partners has bought into BioEcho Life Sciences, a maker of nucleic acid purification solutions for molecular diagnostics and life sciences research.
The post Covid-testing component maker BioEcho gets Ampersand Capital backing first appeared on AltAssets Private Equity News.
